Section 12-15-35-47 - Review of changes to formulary(a) This section applies to the following changes to a formulary used by a managed care organization for Medicaid recipients:(1) Removing one (1) or more drugs from the formulary.(2) Placing new restrictions on one (1) or more drugs on the formulary.(b) Before a managed care organization makes a change described in subsection (a), the managed care organization shall submit the proposed change to the office.(c) The office shall forward the proposed change to the board for the board's review and recommendation.(d) The office shall provide at least thirty (30) days notification to the public that the board will: (1) review the proposed change; and(2) consider evidence and credible information provided to the board; at the board's regular board meeting before making a recommendation to the office regarding whether the proposed change should be approved or disapproved.
(e) Based on the final recommendation of the board, the office may approve or disapprove the proposed change. If a proposed change is not disapproved within ninety (90) days after the date the managed care organization submits the proposed change to the office, the managed care organization may implement the change to the formulary.(f) A managed care organization: (1) may add a drug to the managed care organization's formulary without the approval of the office; and(2) shall notify the office of any addition to the managed care organization's formulary within thirty (30) days after making the addition.Amended by P.L. 152-2017,SEC. 30, eff. 7/1/2017.As added by P.L. 231-1999, SEC.9.